Zydelig (idelalisib)

pCPA File Number: 20829
Negotiation Status:
Concluded with an LOI
Indication(s):
Chronic lymphocytic leukemia
Sponsor/Manufacturer:
Gilead Sciences Canada Inc.
CDA-AMC Project Number:
PC0057-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: